Primary component in turmeric kicks off cancer-killing mechanisms in human saliva
Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive ...
Cancer
Sep 13, 2011 |
5 / 5 (12) |
2
|
New tumor suppressor gene identified
A recent study published in Clinical Cancer Research suggests that the protein hVps37A suppresses tumor growth in ovarian cancer. The work, which was funded by the Austrian Science Fund FWF, shows, for th ...
Cancer
Feb 13, 2012 |
4.8 / 5 (4) |
0
Queen's pioneers prostate cancer breakthrough
Scientists at Queen's University have pioneered a new combination treatment for prostate cancer. The treatment, which has been successful in phase one of trials, will now be tested for efficacy in a second phase.
Cancer
Sep 19, 2011 |
5 / 5 (3) |
0
Oxygen in tumors predicts prostate cancer recurrence
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy.
Cancer
Apr 01, 2012 |
5 / 5 (3) |
0
Grapefruit juice lets patients take lower dose of cancer drug
A glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself, according to a new clinical trial. The combination ...
Cancer
Aug 07, 2012 |
5 / 5 (3) |
0
|
Patient's own immune cells may blunt viral therapy for brain cancer
Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors. Clinical trials show that these therapeutic viruses are safe but less effective than expected.
Cancer
Nov 25, 2012 |
3.7 / 5 (3) |
0
|
Study shows anti-copper drug might prevent the spread of cancer to organs
An anti-copper drug compound that disables the ability of bone marrow cells from setting up a "home" in organs to receive and nurture migrating cancer tumor cells has shown surprising benefit in one of the most difficult-to-treat ...
Cancer
Feb 13, 2013 |
5 / 5 (2) |
1
|
Clinical trial finds new class of cancer drugs safe and effective
The safety and preliminary efficacy of a new class of tumor fighting drugs were reported today by Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen).
Cancer
Apr 09, 2013 |
5 / 5 (2) |
0
New drug enhances radiation treatment for brain cancer in preclinical studies
A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma ...
Cancer
May 14, 2013 |
5 / 5 (2) |
0
PI3-kinase and PARP inhibitor combo may offer new treatment option for triple-neg breast cancers
The simultaneous inhibition of two separate and seemingly unrelated pathways could potentially provide an effective treatment for women with triple-negative breast cancer, according to results of two studies published in ...
Cancer
Nov 12, 2012 |
4 / 5 (2) |
0
Combination therapy may enhance gemcitabine activity
Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer Di ...
Cancer
Feb 28, 2012 |
3 / 5 (2) |
0
Arginine restores T-cell ability to target cancer
In many cases, tumors suppress a patient's immune system in a way that keeps the cancer safe from immune system attack. This is particularly true for patients with glioblastoma, a primary brain tumor that carries a prognosis ...
Cancer
Nov 22, 2011 |
5 / 5 (1) |
0
First prospective clinical trial of adaptive radiotherapy for head and neck cancer patients
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy ...
Cancer
Feb 09, 2012 |
5 / 5 (1) |
0
Scientists reprogram cancer cells with low doses of epigenetic drugs
Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The drugs, azacitidine (AZA) ...
Cancer
Mar 22, 2012 |
5 / 5 (1) |
0
|
Genetic abnormality offers diagnostic hope for children's cancer
A chromosomal abnormality in children with a deadly form of brain cancer is linked with a poorer chance of survival, clinician scientists at The University of Nottingham have discovered.
Cancer
Mar 28, 2012 |
5 / 5 (1) |
0
|
